Abbott India Ltd has informed BSE that the Boards of Directors of Abbott India Ltd. ('Abbott India') and Solvay Pharma India Ltd. ('Solvay Pharma India'), at their meetings held on November 24, 2010, have unanimously approved the draft scheme for the amalgamation of Solvay Pharma India into Abbott India under sections 391 to 394 of the Companies Ac 1956. The swap ratio for the merger was recommended by Ernst &, Young Pvt. Ltd. and Pricewaterhouse Coopers Pvt. Ltd. (respectively to Abbott India and Solvay Pharma India). UBS Securties India Pvt. Ltd. and DSP Merrill Lynch Ltd. have provided fairness opinions on the valuation of assets/shares to the boards of Solvay Pharma India and Abbott India respectively. The swap ratio for the merger is 2:3. In other words, every two share(s) of the Solvay Pharma India Ltd. will entitle their holder to three shares of Abbott India Ltd. Abbott India Ltd has informed BSE that pursuant to the Order dated February 11, 2011 passed by the Hon'ble High Court of Bombay in Company Summons for directions No. 106 of 2011, the Court Convened Meeting of the Equity Shareholders of the Company for considering and approving the Scheme of Amalgamation of Solvay Pharma India Limited (the Transferor Company) with the Company was held on March 23, 2011. (As Per BSE Announcement Dated on 23.03.2011) Abbott India Ltd has informed BSE that the Hon'ble High Court of Bombay, on July 15, 2011, has sanctioned the Scheme of Amalgamation of Solvay Pharma India Limited, the Transferor Company with Abbott India Limited, the Transferee Company. (As Per BSE Announcement Dated on 15.07.2011) Abbott India Ltd has informed BSE that the Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd with Abbott India Ltd has been filed with the Registrar of Companies, Maharashtra today i.e. August 10, 2011. (As Per BSE Announcement Website dated on 10.08.2011) Solvay Pharma India Ltd has informed BSE that the Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. has been filed with the Registrar of Companies, Maharashtra, on August 10, 2011. (As Per BSE Announcement Website dated on 11.08.2011) Abbott India Ltd has informed BSE that it has fixed August 29, 2011 as the Record Date for the purpose of determining the entitlement of shareholders of Solvay Pharma India Ltd, who will be allotted shares of Abbott India Ltd, in terms of the Share Swap Ratio of 2:3. Abbott India Ltd has informed BSE that it has fixed August 29, 2011 as the Record Date for the purpose of determining the entitlement of shareholders of Solvay Pharma India Ltd, who will be allotted shares of Abbott India Ltd, in terms of the Share Swap Ratio of 2:3. (As Per BSE Announcement Website dated on 19.08.2011) SUB. : - Scheme of Amalgamation of Solvay Pharma India Ltd. (Scrip Code 532447) Trading members of the Exchange are hereby informed that, Abbott India Ltd. has fixed a Record Date to determine the entitlement of shareholders of Solvay Pharma India Ltd., pursuant to the sanctioned Scheme of Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. Trading Members are advised not to deal in the equity shares of Solvay Pharma India Ltd. with effect from the under mentioned date. COMPANY NAME CODE Solvay Pharma India Ltd. (532447) RECORD DATE 29.08.2011 PURPOSE Scheme of Amalgamation: - Amalgamation of Solvay Pharma India Ltd. with Abbott India Ltd. Upon the Scheme becoming effective and upon vesting of Solvay Pharma India Ltd. in Abbott India Ltd., Abbott India Ltd. shall issue and allot equity shares of Rs. 10/- (RUPEES TEN) each credited as fully paid up in the ratio of 3 (THREE) equity shares of Rs. 10/- (RUPEES TEN) each in Abbott India Ltd, for every 2 (TWO) equity shares of Rs. 10/- (RUPEES TEN) each held in Solvay Pharma India Ltd. NO DEALINGS FROM 26/08/2011 DR-104/2011-2012 Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 24.08.2011) Abbott India Ltd has informed BSE that the Committee of Directors appointed for purpose of allotment of shares has at its meeting held September 07, 2011 allotted 75,74,062 equity shares of Rs. 10 each of the Company to the shareholders of Solvay Pharma India Ltd in the ratio of 2:3, in terms of the Scheme of Amalgamation of olvay Pharma India Ltd with the Company. No fractional coupons have been issued / allotted by the Company in respect of any fractional share entitlements. Shareholders of erstwhile Solvay Pharma Ind Ltd holding less than 2 shares or having entitlement in fractions will be paid off in cash based on the Opening Price on the date of allotment i.e. opening price as on September 07, 2011. (As Per BSE Annoncement Website Dated on 07/09/2011)